Search

Subject AMKL -- ELAM02 -- pediatric acute megakaryoblastic leukemia

1. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial. (17th November 2017)

Authors:
Teyssier, Anne-Charlotte; Lapillonne, Hélène; Pasquet, Marlene; Ballerini, Paola; Baruchel, André; Ducassou, Stephane; Fenneteau, Odile; Petit, Arnaud; Cuccuini, Wendy; Ragu, Christine; Preudhomme, Claude; Mercher, Thomas; Sirvent, Nicolas; Leverger, Guy
Journal:
Pediatric hematology and oncology
Issue:
Volume 34:Number 8(2017)
Page Start:
425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • AMKL -- ELAM02 -- pediatric acute megakaryoblastic leukemia 1